RANK Ligand Inhibitor class drugs
1 result
Xgeva (denosumab)
(denosumab)Amgen Inc
Usage: Xgeva is indicated for preventing skeletal-related events in multiple myeloma and bone metastases from solid tumors. It also treats unresectable giant cell tumor of bone in adults and skeletally mature adolescents, and manages hypercalcemia of malignancy that is refractory to bisphosphonate therapy.